SSY Stock | | | USD 0.75 0.01 1.32% |
President
Mr. Byron D. Finn, CPA, is a President of SunLink ScriptsRx, LLC. of the Company. Mr. Finn was President of Byron D. Finn, CPA, PC, which provided accounting, financial consulting, and litigation support services for clients, including numerous healthcare clients. His experience also includes various positions with The CocaCola Company, where he served in a number of financialrelated positions and in connection with special projects, and he was previously employed by Ernst Young since 2010.
Age | 68 |
Tenure | 14 years |
Professional Marks | CPA |
Address | 900 Circle 75 Parkway, Atlanta, GA, United States, 30339 |
Phone | 770 933 7000 |
Web | https://www.sunlinkhealth.com |
Finn is a licensed CPA and received his BA in Business Administration and Master in Accountancy degrees from the University of Georgia.
SunLink Health Management Efficiency
The company has Return on Asset of
(0.0954) % which means that on every $100 spent on assets, it lost $0.0954. This is way below average. In the same way, it shows a return on shareholders' equity
(ROE) of
(0.1476) %, meaning that it generated no profit with money invested by stockholders. SunLink Health's management efficiency ratios could be used to measure how well SunLink Health manages its routine affairs as well as how well it operates its assets and liabilities. At this time, SunLink Health's
Return On Tangible Assets are fairly stable compared to the past year.
Return On Assets is likely to rise to 0.01 in 2024, despite the fact that
Return On Capital Employed is likely to grow to
(0.04). At this time, SunLink Health's
Total Assets are fairly stable compared to the past year.
Total Current Assets is likely to rise to about 24.9
M in 2024, whereas
Non Current Assets Total are likely to drop slightly above 4.7
M in 2024.
SunLink Health Systems has 528
K in debt with debt to equity
(D/E) ratio of 0.07, which may show that the company is not taking advantage of profits from borrowing. SunLink Health Systems has a current ratio of 2.15, demonstrating that it is
liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for SunLink to invest in growth at high rates of return.
Similar Executives
Found 1 records | PRESIDENT Age |
| Peter Lee | Leafly Holdings | 47 |
SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States. SunLink Health Systems, Inc. was founded in 1959 and is based in Atlanta, Georgia. Sunlink Health operates under Pharmaceutical Retailers classification in the United States and is traded on AMEX Exchange. SunLink Health Systems (SSY) is traded on NYSE MKT Exchange in USA. It is located in 900 Circle 75 Parkway, Atlanta, GA, United States, 30339 and employs 14 people. SunLink Health is listed under Health Care Providers & Services category by Fama And French industry classification.
Management Performance
SunLink Health Systems Leadership Team
Elected by the shareholders, the SunLink Health's board of directors comprises two types of representatives: SunLink Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of SunLink. The board's role is to monitor SunLink Health's management team and ensure that shareholders' interests are well served. SunLink Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, SunLink Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| C Ford, Independent Director | |
| James Mulligan, General Emeritus | |
| Sheila Brockman, Vice President | |
| Mark Stockslager, Chief Financial Officer, Principal Accounting Officer | |
| Theresa Mota, Secretary | |
| Byron CPA, LLC ScriptsRX | |
| Gene Burleson, Independent Director | |
| Karen Brenner, Independent Director | |
| Howard Turner, Independent Director | |
| Steven Baileys, Independent Director | |
| Christopher Mills, Independent Director | |
| Byron Finn, President of SunLink ScriptsRx, LLC. | |
| Robert Thornton, Executive Chairman, CEO and President and Chairman of Executive Committee | |
| Neal Miller, Inc Technology | |
SunLink Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is SunLink Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for SunLink Stock Analysis
When running SunLink Health's price analysis, check to
measure SunLink Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SunLink Health is operating at the current time. Most of SunLink Health's value examination focuses on studying past and present price action to
predict the probability of SunLink Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SunLink Health's price. Additionally, you may evaluate how the addition of SunLink Health to your portfolios can decrease your overall portfolio volatility.